@Article{grunau2021higher,
  title = {A Higher Antibody Response Is Generated With a 6-to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval},
  author = {Brian Grunau and Michael Asamoah-Boaheng and Pascal M Lavoie and Mohammad Ehsanul Karim and Tracy L Kirkham and Paul A Demers and Vilte Barakauskas and Ana Citlali Marquez and Agatha N Jassem and Sheila F O'Brien and {others}},
  journal = {Clinical infectious diseases: an official publication of the Infectious Diseases Society of America},
  year = {2021},
  publisher = {Oxford University Press},
  date = {2021-01-01},
}
